New insider activity at UnitedHealth ( (UNH) ) has taken place on May 17, 2025.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Recent transactions in UnitedHealth stock reveal significant purchases by key executives and directors. CEO Stephen Hemsley led the charge with an acquisition of 86,700 shares valued at $25,019,019. President & CFO John F. Rex followed with a purchase of 17,175 shares worth $4,999,814. Director Timothy Patrick Flynn acquired 1,533 shares for $491,786, while Director Kristen Gil bought 3,700 shares at a cost of $1,003,329. Additionally, Director John H. Noseworthy invested in 300 shares, amounting to $93,645.
Recent Updates on UNH stock
UnitedHealth has experienced significant developments recently, leading to notable changes in its stock price and analyst ratings. The company suspended its 2025 guidance due to worsening trends in Medicare Advantage, which have spread to more complex patients. This has led analysts like BofA’s Joanna Gajuk to downgrade the stock and lower price targets, citing uncertainty and a lack of near-term catalysts. Additionally, UnitedHealth’s leadership transition, with Andrew Witty stepping down as CEO and Stephen Hemsley returning, has added to the market’s concerns. Raymond James also downgraded the stock, highlighting the unexpected retraction of guidance and low visibility for the remainder of 2025. Despite these challenges, UnitedHealth expects to return to growth in 2026, although it may face flat or negative member growth as it focuses on restoring margins.
Spark’s Take on UNH Stock
According to Spark, TipRanks’ AI Analyst, UNH is a Neutral.
UnitedHealth’s overall score reflects a solid financial position with strong revenue growth and effective cash management. However, declining profitability metrics, bearish technical indicators, and recent corporate events such as the CEO transition temper the outlook. The earnings call highlighted growth opportunities but also underscored challenges, affecting sentiment. While valuation remains balanced, offering a moderate dividend yield, the company faces near-term challenges that could impact stock performance.
To see Spark’s full report on UNH stock, click here.
More about UnitedHealth
YTD Price Performance: -45.53%
Average Trading Volume: 10,313,368
Technical Sentiment Signal: Sell
Current Market Cap: $279.4B